Commentary
Clostridium difficile: a formidable foe
Vivian G. Loo, Michael D. Libman, Mark A. Miller, Anne-Marie Bourgault, Charles H. Frenette, Mirabelle Kelly, Sophie Michaud, Tuyen Nguyen, Louise Poirier, Anne Vibien, Ruth Horn, Pierre J. Laflamme and Pierre René
CMAJ July 06, 2004 171 (1) 47-48; DOI: https://doi.org/10.1503/cmaj.1040836
Vivian G. Loo
Michael D. Libman
Mark A. Miller
Anne-Marie Bourgault
Charles H. Frenette
Mirabelle Kelly
Sophie Michaud
Tuyen Nguyen
Louise Poirier
Anne Vibien
Ruth Horn
Pierre J. Laflamme

Article Figures & Tables
There are no figures or tables available.
In this issue
CMAJ
Vol. 171, Issue 1
6 Jul 2004
Article tools
Respond to this article
Clostridium difficile: a formidable foe
Vivian G. Loo, Michael D. Libman, Mark A. Miller, Anne-Marie Bourgault, Charles H. Frenette, Mirabelle Kelly, Sophie Michaud, Tuyen Nguyen, Louise Poirier, Anne Vibien, Ruth Horn, Pierre J. Laflamme, Pierre René
CMAJ Jul 2004, 171 (1) 47-48; DOI: 10.1503/cmaj.1040836
Clostridium difficile: a formidable foe
Vivian G. Loo, Michael D. Libman, Mark A. Miller, Anne-Marie Bourgault, Charles H. Frenette, Mirabelle Kelly, Sophie Michaud, Tuyen Nguyen, Louise Poirier, Anne Vibien, Ruth Horn, Pierre J. Laflamme, Pierre René
CMAJ Jul 2004, 171 (1) 47-48; DOI: 10.1503/cmaj.1040836
Related Articles
Cited By...
- Antiapoptotic Proteins Bcl-2 and Bcl-XL Inhibit Clostridium difficile Toxin A-Induced Cell Death in Human Epithelial Cells
- Prevention and control of infections in the home
- Hypervirulent strains of Clostridium difficile
- Analysis of Proline Reduction in the Nosocomial Pathogen Clostridium difficile
- Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review
- First, the bad news...
- D'abord, la mauvaise nouvelle ...